Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
3(60%)

Phase Distribution

Ph phase_1
4
80%
Ph phase_2
1
20%

Phase Distribution

4

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(2)
Terminated(3)

Detailed Status

Terminated3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
40.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (80.0%)
Phase 21 (20.0%)

Trials by Status

completed240%
terminated360%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_2

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

NCT02317783
terminatedphase_1

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

NCT01246869
completedphase_1

A Multi-modality Imaging Assessment of Chemobrain

NCT00708045
terminatedphase_1

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

NCT00707213
completedphase_1

Multi-Tracer PET Assessment of Primary Brain Tumors

NCT00813566

Clinical Trials (5)

Showing 5 of 5 trials
NCT02317783Phase 2

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Terminated
NCT01246869Phase 1

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Terminated
NCT00708045Phase 1

A Multi-modality Imaging Assessment of Chemobrain

Completed
NCT00707213Phase 1

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

Terminated
NCT00813566Phase 1

Multi-Tracer PET Assessment of Primary Brain Tumors

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5